Literature DB >> 21673448

Protective effect of taurine on diabetic rat endothelial dysfunction.

Natsuko Ikubo1, Motoaki Saito, Panagiota Tsounapi, Fotios Dimitriadis, Fumiya Ohmasa, Seiya Inoue, Shogo Shimizu, Yukako Kinoshita, Keisuke Satoh.   

Abstract

As increasing evidence suggest that oxidative stress plays an important role in the developing angiopathy in diabetes, we studied the effects of taurine, a free radical scavenger, on diabetes induced angiopathy in the rat aorta. Six-week-old male Wistar rats were randomly divided into three groups; control group (Cont), diabetes group (DM) and diabetes group treated with taurine for four weeks, 500 mg/kg/day, intraperitoneally (i.p.) (DM+T). Diabetes was induced by streptozotocin (50 mg/kg i.p.). Four weeks after the induction of diabetes, serum glucose and malondialdehyde concentrations were measured. Additionally, organ bath studies and real-time PCR on muscarinic M(3) receptor and eNOS were performed. Although taurine treatment failed to decrease serum glucose levels, the increased serum malondialdehyde levels in diabetic rats were significantly decreased after taurine treatment. Norepinephrine-induced hyper-contractility as well as acetylcholine-induced, endothelium-dependent hypo-relaxation in diabetes were significantly prevented after taurine treatment. The differences in the expressions of muscarinic M(3) receptor mRNAs were statistically non-significant between groups. Moreover, diabetes-induced up-regulation of eNOS mRNAs was slightly prevented after taurine treatment. These data suggest that taurine acts beneficially against the diabetes-induced vascular dysfunction. Its potential action as a radical scavenger ameliorates the vascular disorders in diabetes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21673448     DOI: 10.2220/biomedres.32.187

Source DB:  PubMed          Journal:  Biomed Res        ISSN: 0388-6107            Impact factor:   1.203


  6 in total

Review 1.  Ameliorative effects of taurine against diabetes: a review.

Authors:  Fengyuan Piao; Rana Muhammad Aadil; Raheel Suleman; Kaixin Li; Mengren Zhang; Pingan Wu; Muhammad Shahbaz; Zulfiqar Ahmed
Journal:  Amino Acids       Date:  2018-02-28       Impact factor: 3.520

2.  Sexual dimorphism in rat aortic endothelial function of streptozotocin-induced diabetes: possible involvement of superoxide and nitric oxide production.

Authors:  Xiaoyuan Han; Rui Zhang; Leigh Anderson; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2013-11-06       Impact factor: 4.432

3.  Oxidative Stress Alterations in the Bladder of a Short-period Type 2 Diabetes Rat Model: Antioxidant Treatment Can Be Beneficial for the Bladder.

Authors:  Panagiota Tsounapi; Masashi Honda; Katsuya Hikita; Nikolaos Sofikitis; Atsushi Takenaka
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

4.  Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes.

Authors:  Kyoung Soo Kim; Da Hee Oh; Jung Yeon Kim; Bong Gn Lee; Jeong Soon You; Kyung Ja Chang; Hyun Ju Chung; Myung Chul Yoo; Hyung In Yang; Ja Heon Kang; Yoo Chul Hwang; Kue Jeong Ahn; Ho Yeon Chung; In Kyung Jeong
Journal:  Exp Mol Med       Date:  2012-11-30       Impact factor: 8.718

5.  Taurine supplementation reduces blood pressure and prevents endothelial dysfunction and oxidative stress in post-weaning protein-restricted rats.

Authors:  Aline R Maia; Thiago M Batista; Jamaira A Victorio; Stefano P Clerici; Maria A Delbin; Everardo M Carneiro; Ana P Davel
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

Review 6.  Effects and Mechanisms of Taurine as a Therapeutic Agent.

Authors:  Stephen Schaffer; Ha Won Kim
Journal:  Biomol Ther (Seoul)       Date:  2018-05-01       Impact factor: 4.634

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.